DSM-Firmenich AG
Total Valuation
CHFAs of June 30, 2026, DSM-Firmenich AG carries a market capitalization of 18.60B, placing it among publicly traded companies globally. Its enterprise value stands at 22.85B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 18.60B |
| Enterprise Value | 22.85B |
Important Dates
DSM-Firmenich AG's next confirmed earnings release is scheduled for February 18, 2027.
| Earnings Date | 2/18/2027 |
Share Statistics
As of June 30, 2026, DSM-Firmenich AG has 247.17M shares outstanding.
| Shares Outstanding | 247.17M |
Valuation Ratios
These figures are as of June 30, 2026.
| PB Ratio | 1.13 |
| P/TBV Ratio | 7.78 |
Financial Position
As of June 30, 2026, DSM-Firmenich AG maintains a current ratio of 1.75, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.75 |
| Quick Ratio | 0.40 |
| Debt / Equity | 37.64 |
Financial Efficiency
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 28,550.00 |
Balance Sheet
CHFAs of June 30, 2026, DSM-Firmenich AG holds 2.13B in cash and equivalents against 6.24B in total debt, resulting in a net debt position of 4.16B. Total book value stands at 16.45B, with working capital of 3.94B providing operational flexibility.
| Cash & Cash Equivalents | 2.13B |
| Total Debt | 6.24B |
| Net Debt | 4.16B |
| Equity (Book Value) | 16.45B |
| Book Value Per Share | 66.56 |
| Working Capital | 3.94B |